Clinical research in the UK must build on industry collaboration, says NIHR director
Last month, the Labour government came into power in the UK after almost two decades, with a plan to “kickstart…
Interviews
How NVIDIA grew with the healthcare market instead of pushing into it
Drug development costs predicted to soar as BIOSECURE Act gains momentum
Boehringer Ingelheim plans sustainability work for the long term
Q&A: Cell and gene therapy value assessments need a rework to allow access
Q&A: BARDA wants to back tech that can combat multiple infections, says director
Q&A: Increasing awareness around digital therapeutics key to realising full potential
Q&A: Regulatory reform necessary to improve obesity drug access
